Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

V.a

Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

Publications

Ceyhan ST, Goktolga U, Karasahin E, Alanbay I, Duru NK

Continuous vaginal and bilateral thoracic fluid drainage for management of severe ovarian hyperstimulation syndrome.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2008 Sep;24;505-7 — 2008 Sep — 505-7

Calvo-Romero JM, Lima-Rodríguez EM

Bilateral pleural effusion and ascites in the ovarian hyperstimulation syndrome.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine 2004 Dec;11;348-50 — 2004 Dec — 348-50

Cordani S, Bancalari L, Maggiani R, La Sala GB, Fiasella F, Canessa PA

Massive unilateral hydrothorax as the only clinical manifestation of ovarian hyperstimulation syndrome.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2002 Oct-Dec;57;314-7 — 2002 Oct-Dec — 314-7